Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Biguanide-salts

 Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives
OF THE INVENTION A hapten of the invention is substantially optically pure, and is particularly ...


 Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C
What is claimed is: 1. Composition of matter consisting essentially of polyclonal antibodies which ...


 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
The present invention overcomes the above mentioned drawbacks and provides methods for treating ...


 Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay
OF THE INVENTION The present invention is directed to methods for developing and utilizing ...


 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
The invention claimed is: 1. An oral pharmaceutical formulation comprising phytosterols and isomers ...


 Stimulation of chemotaxis by chemotactic peptides
Accordingly, it is an object of this invention to provide a synthetic material having chemotactic ...


 Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ...


 Diagnosis of Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams ...


 Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ...


 Method for bonding or fusion of biological tissue and material
Biological materials are joined, repaired or fused by heating the material in proximity to a ...


 Biguanide salts

Details
Inventors: Fischer, Ulf; Lorch, Eckehard;
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Primary Examiner: Helfin; Bernard
Assistant Examiner: Breitenstein; G. T.
Attorney, Agent or Firm: Welt; Samuel L., Leon; Bernard S., Isgro; William G.

Biguanide salts of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and n are as hereinafter set forth, are described. The aforementioned biguanides are useful as hypoglycemic agents.

DETAILED DESCRIPTION OF THE INVENTION The invention relates to biguanide salts.
In another aspect, the invention relates to pharmaceutical preparations which contain the aforementioned biguanide salts.
The biguanide salts of the invention are characterized by the formula ##STR4## wherein R.
sup.
1 is hydrogen, lower alkyl or lower alkenyl; R.
sup.
2 is lower alkyl, aryl, aryl-lower alkyl, or aryloxy-lower alkyl; or R.
sup.
1 and R.
sup.
2, taken together, are lower alkylene; R.
sup.
3 is hydrogen or a residue of the formula ##STR5## wherein R.
sup.
4 and R.
sup.
5 are hydrogen or a cation, or R.
sup.
4 is hydrogen and R.
sup.
5 is lower alkyl, or R.
sup.
4 and R.
sup.
5, taken together, are lower alkylene; and n is 1 to 2.
As used herein, the term "lower alkyl" denotes an alkyl group of 1-7 carbon atoms, for example, methyl, ethyl, propyl, isopropyl, butyl, isomers thereof, and the like.
The term "lower alkenyl" denotes an alkenyl group of 2-7 carbon atoms, for example, vinyl, allyl, and the like.
The term "aryl" denotes an aromatic hydrocarbon radical, for example, phenyl, which may contain one or more substituents, such as, for example, lower alkyl, lower alkoxy and halogen.
Halogen denotes chlorine, bromine, fluorine, and iodine; preferably chlorine.
As used herein, the term "cation" denotes a cation such as, Na.
sup.
+, K.
sup.
+ or NH.
sub.
4 .
sup.
+; Ca.
sup.
+.
sup.
+, Mg.
sup.
+.
sup.
+.
The term "lower alkylene" denotes an alkylene group having 2-7 carbon atoms such as ethylene, trimethylene, tetramethylene and penta methylene.
Compounds of formula I wherein R.
sup.
1 is hydrogen or lower alkyl, R.
sup.
2 is lower alkyl or phenyl-lower alkyl and R.
sup.
3 is hydrogen are preferred.
Examples of the compounds of formula I are: 1-phenethylbiguanide mono-dichloroacetate, 1-phenethylbiguanide bis-dichloroacetate, 1-n-butylbiguanide mono-dichloroacetate, 1-n-butylbiguanide bis-dichloroacetate, 1,1-dimethylbiguanide mono-dichloroacetate, 1,1-dimethylbiguanide bis-dichloroacetate, 1-pentylbiguanide mono-dichloroacetate, 1-pentylbiguanide bis-dichloroacetate, 1-isopentylbiguanide mono-dichloroacetate, 1-isopentylbiguanide bis-dichloroacetate, 1-benzyl-1-methylbiguanide mono-dichloroacetate, 1-benzyl-1-methylbiguanide bis-dichloroacetate, 1-benzyl-5-phosphorylbiguanide (benfosformin) mono di-chloroacetate, or the like



Related patents
  Inhibitors of dipeptidyl-aminopeptidase type IV
What is claimed is: 1. A method for treating transplant rejection in a patient comprising administering to said patient an inhibitor of DP-IV, having the structure: ##STR...
  Process for preparing anti-obesity protein
OF THE INVENTION For purposes of the present invention, as disclosed and claimed herein, the following terms and abbreviations are as defined below. dDAP--a ...
  Use of GLP-1 or analogs to abolish catabolic changes after surgery
The present invention therefore presents for the first time a method of attenuating post-surgical catabolic changes and insulin resistance, comprising, administering to ...
  Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury
OF THE INVENTION The present invention provides a method for effective treatment of spinal cord injury. The method involves administering an effective amount of ...
  Leptospira rare outer membrane proteins
The present invention presents two novel leptospiral membrane proteins: LipL1 and LipL2. In particular, these proteins are lipoproteins which are associated with ...
  Interleukin-1 beta converting enzyme like apoptotic protease-6
Toward these ends, and others, it is an object of the present invention to provide polypeptides, inter alia, that have been identified as novel ICE LAP-6 by homology ...
  Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
What is claimed is: 1. A therapeutic composition comprising at least one angiogenesis inhibiting agent, which is an .alpha..sub.v.beta..sub.3 antagonist; and at least ...
  Expressed sequence tags and encoded human proteins
The present invention relates to purified, isolated, or enriched 5' ESTs which include sequences derived from the authentic 5' ends of their corresponding mRNAs. The ...
  C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
The invention claimed is: 1. An isolated PC-LECTIN protein comprising the amino acid sequence of SEQ ID NO. 2. 2. The PC-LECTIN protein of claim 1 which is soluble. 3. ...
  Antibodies for use in determining hemoglobin A.sub.1c
It is accordingly an object of the present invention to provide a comparatively simple, inexpensive, reliable test for determining the long-term blood sugar level of a ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved